Objective: This study was conducted to explore the association of microRNA (miR)-125a and miR-125b with acute respiratory distress syndrome (ARDS) risk and to investigate their correlation with clinical characteristics and prognosis in sepsis patients.
| INTRODUC TI ON
Sepsis is defined as a dysregulated host response to infection which is correlated with a life-threatening organ dysfunction. 1 As a major public health concern, sepsis accounts for considerable healthcare costs and serves as a leading cause of critical illness and mortality globally with an increasing incidence and in-hospital mortality rate of 15%-25%. 2, 3 The effective treatments for sepsis include timely removal of the source of infection and appropriate antimicrobial therapy; however, the prognosis of most sepsis patients is still unfavorable. 4 Acute respiratory distress syndrome (ARDS), as the most common and serious complication of sepsis, is a pulmonary dysfunction due to various causes, such as systemic inflammation and uncontrolled cytokine, leading to increased mortality in sepsis patients. 5 Therefore, it is essential to explore the biomarkers for predicting ARDS risk and monitoring the prognosis in sepsis patients.
MicroRNAs (miRNA) are universal non-coding RNAs that regulate the expressions of target genes via inhibiting the translation or depredation of mRNA and accumulating evidences indicate that miRNAs are involved in the regulation of the immune response and inflammation. 6, 7 MiR-125a and miR-125b, which belong to miR-125 family, have been reported to be involved in various processes of immune responses and inflammation. 8, 9 For instance, miR-125a high expression is reported to contribute to the upregulation of inflammatory cytokines and chemokines, such as IL-β, IL-6, and TNF-α, in lupus nephritis. 10 As for miR-125b, its overexpression elevated the expressions of proinflammatory factors including TNF-α, IL-6, IL-1β, and p-p65 via activating NF-κB pathway, meanwhile its involvement in the immune response and inflammation is reported in acute lung injury. 11, 12 In addition, the regulatory roles of miR-125a as well as miR-125b in reactive oxygen species (ROS) level, which is associated with oxygen and glucose deprivation, are reported in several organs including lung. 13, 14 Considering the association of miR-125a and miR-125b with proinflammatory factors in immune, inflammation responses and their regulating roles in lung injuries, we hypothesized that they might be of value in predicting ARDS risk as well as prognosis in sepsis patients. However, no related research has been conducted before. Thus, we performed this study to explore the association of miR-125a and miR-125b with ARDS risk and investigated its correlation with clinical characteristics as well as the prognosis in sepsis patients.
| MATERIAL S AND ME THODS

| Participants
In our emergency department, there were 85 beds (including 10 beds of respiratory intensive care unit), and we had a medical center with various high-tech treatments including mechanical ventilation and respiratory mechanics monitoring, hemodynamic monitoring and treatment, blood purification, and severe ultrasound. The inclusion criteria were as follows: (a) diagnosed as sepsis in line with the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3); 15 (b) age ≥18 years; (c) no history of cancers or haematological malignancies. The exclusion criteria included the following: (a) died within 24 hours after admission; (b) infected with human immunodeficiency virus; (c) received immunosuppressive therapy within 6 months; (d) pregnant or lactating women. In addition, 150 healthy subjects who underwent physical examination in our hospital were enrolled as healthy controls (HCs). The screen criteria of HCs were as follows: (a) age above 18 years old; (b) had no history of sepsis or malignancies; (c) had no obvious abnormalities confirmed by physical examination; (d) not pregnant or lactating women. This study was approved by the Ethics Committee of our hospital. All participants or their guardians provided written informed consents before enrollment.
| Clinical data collection
Clinical characteristics of sepsis patients were documented after enrollment, including age, gender, body mass index (BMI), smoke status, and chronic comorbidities (such as chronic obstructive pulmonary disease [COPD], cardiomyopathy, chronic kidney failure, and cirrhosis). The laboratory indexes measured immediately after admission, such as serum creatinine (Scr), albumin, white blood cell (WBC), and C-reactive protein (CRP), were also recorded. Besides, the acute physiology and chronic health evaluation (APACHE) II score and the sequential organ failure assessment (SOFA) score were documented as well, which were evaluated within 24 hours after admission and used to assess severity of sepsis and severity of organ dysfunction.
| Sample collection
Blood samples of all sepsis patients were collected within 24 hours after admission, and the blood samples of HCs were collected on the enrollment. All blood samples were centrifuged at 1600 g for 10 minutes at 4°C. Subsequently, the supernatants were separated into Eppendorf tubes and further centrifuged at 12 000 g for 10 minutes at 4°C. Finally, the plasma was obtained and stored at −80°C until determination. 
| MiR-125a and miR-125b detection
| Treatment and follow-up
Standard treatments and resuscitation were administered to patients after the diagnosis was established, which were performed as recommended by the International Guidelines for Management of Sepsis and Septic Shock. 16 All patients were followed up for 28 days, and the patients who died during follow-up were recorded for evaluation of 28days mortality. All patients were categorized into survivors and deaths according to the survival status during 28-days follow-up.
| Acute respiratory distress syndrome (ARDS) assessment
During the hospitalization, close surveillance was conducted for all patients, especially for the patients with risk factors such as pneumonia, inhalational injury, pulmonary contusion, and so on. The patients who developed ARDS were documented for assessment of ARDS incidence. The ARDS was confirmed on the basis of onset time, chest imaging (chest X-ray or CT scan) and the origin of edema, which was in accordance with the 2012 Berlin ARDS definition. 17 According to whether ARDS occurred or not, all sepsis patients were categorized as ARDS-sepsis patients and non-ARDS-sepsis patients. 
| Statistical analysis
| RE SULTS
| Comparison of characteristic between ARDSsepsis patients and non-ARDS-sepsis patients
The mean age of total sepsis patients was 56.9 ± 10.3 years, and there were 52 females and 98 males ( Table 1 ). The mean APACHE II score and SOFA score were 16.3 ± 6. Table 1 .
| Comparison of miR-125a and miR-125b among HCs, non-ARDS-sepsis patients, and ARDSsepsis patients
MiR-125a and miR-125b relative expression was increased in ARDSsepsis patients (both P < .001)/non-ARDS-sepsis patients (both P < .001) compared with HCs, and miR-125b was also elevated in ARDS-sepsis patients compared with non-ARDS-sepsis patients (P = .001), while miR-125a was numerically elevated in ARDS-sepsis patients compared with non-ARDS-sepsis without statistical significance (P = .052) ( Figure 1A,B ). 
| The values of miR-125a and miR-125b in predicting ARDS risk in sepsis patients
| Factors predicting ARDS risk in sepsis patients
Univariate logistic regression analysis exhibited that miR-125a (OR = 1.952, P = .006), miR-125b (OR = 1.621, P < .001), age were independent predictive factors for higher ARDS risk in sepsis patients ( Table 2) . Abbreviations: APACHE II score, acute pathologic and chronic health evaluation II score; ARDS, acute respiratory distress syndrome; BMI, body mass index; COPD, chronic obstructive pulmonary disease; CRP, C-reactive protein; IQR, interquartile range; Scr, serum creatinine; SD, standard deviation; SOFA score, sequential organ failure assessment score; WBC, white blood cell.
TA B L E 1 Clinical characteristics of sepsis patients
| Correlation of miR-125a and miR-125b with clinical characteristics in sepsis patients
For continuous variables, miR-125a relative expression was positively associated with Scr (r = .207, P = .011), APACHE II score (r = .287, P < .001), and SOFA score (r = .209, P = .010) ( Table 3) .
MiR-125b was positively associated with Scr (r = .238, P = .003), CRP (r = .414, P < .001), APACHE II score (r = .351, P < .001), and SOFA score (r = .278, P = .001). As for the categorical variables, miR-125b was associated with COPD (P = .048) ( Table 4 ). Figure 3B ).
| Comparison of miR-125a and miR-125b between survivors and deaths in sepsis patients
| D ISCUSS I ON
In the present study, we found that in sepsis patients (a) miR-125a
and miR-125b could both predict ARDS risk, and miR-125b was of increased value in predicting ARDS risk compared with miR-125a numerically; (b) miR-125a was associated with renal dysfunction, higher disease severity but not inflammation, and miR-125b was correlated with renal dysfunction, COPD, increased inflammation, and higher disease severity; (c) miR-125b but not miR-125a was upregulated in deaths compared with survivors.
MiR-125a and miR-125b are considered as important factors in the mechanisms of several immune and inflammation responses and play crucial roles in many different cellular processes including cell differentiation, proliferation, and apoptosis. 8, 9, 18, 19 For example, miR-125a is shown to regulate maturation of neutrophils by targeting the major suppressor of G-CSF signaling and neutrophils SOCS3 and serve as an important regulator of granulopoiesis in lung diseases. 20 As for miR-125b, it is elevated in patients with rheumatoid arthritis compared with HCs and the increased expression of miR-125b has been found in patients with other chronic inflammatory arthritis. 21 22 A recent study suggests the correlation of miR-125b
F I G U R E 1 MiR-125a and miR-125b expressions. Comparison of miR-125a between ARDS-sepsis patients and non-ARDS-sepsis patients, between ARDS-sepsis patients and HCs, and between non-ARDS-sepsis patients and HCs (A). Comparison of miR-125b between ARDSsepsis patients and non-ARDS-sepsis patients, between ARDS-sepsis patients and HCs, and between non-ARDS-sepsis patients and HCs
with acute exacerbations of COPD as well as the expressions of inflammatory. 19 Considering the association of miR-125a and miR-125b with lung injuries and inflammation/immune regulation, we hypothesized that miR-125a and miR-125b might have potential for predicting ARDS risk in sepsis patients. In this study, we found that miR-125a and miR-125b relative expressions were increased Abbreviations: APACHE II score, acute pathologic and chronic health evaluation II score; ARDS, acute respiratory distress syndrome; BMI, body mass index; CI, confidence interval; COPD, chronic obstructive pulmonary disease; CRP, C-reactive protein; miR, microRNA; OR, odds ratio; Scr, serum creatinine; SOFA score, sequential organ failure assessment score; WBC, white blood cell. Abbreviations: APACHE II score, acute pathologic and chronic health evaluation II score; BMI, body mass index; CRP, C-reactive protein; miR, microRNA; Scr, serum creatinine; SOFA score, sequential organ failure assessment score; WBC, white blood cell.
TA B L E 3 Correlation of miR-125a
and miR-125b relative expressions with continuous variables in sepsis patients tissue via regulating apoptosis of airway epithelial cells, which combinedly led to increased lung barrier function and the development of lung injury. This was also supported by one of our findings that miR-125b was associated with COPD in sepsis patients. Thus, miR-125a and miR-125b were associated with higher risk of ARDS in sepsis patients. 19 As for the numerically increased predictive value of miR-125b compared with miR-125a in ARDS risk, miR-125b was associated with inflammation, complicated diseases of lung (such as COPD), it might be due to that miR-125b rather than miR-125a was associated with inflammation and complicated diseases of lung (such as COPD) in sepsis patients. It was also interesting to note that were not independent predictive factors for ARDS risk in sepsis patients. This might be supported by one of our results that miR-125a and miR-125b were both positively associated with SOFA score and APACHE II score and that miR-125b was positively correlated with COPD; meanwhile, these three factors were shown to be independent predictive factors for ARDS risk.
Several studies indicate the involvement of miR-125a and miR-125b in inflammatory pathologies and miR-125a and miR-125b
have ability of regulating the secretion of proinflammation chemokines. 19, 21, 22 For example, miR-125b is associated with human osteoarthritis and regulate the secretion of IL-1β and TNF-α. 23 In another study, miR-125b is associated with increased inflammatory cytokines, including TNF-α, IL-8, and LTB-4, and acts as a critical role in the initiation and progression of acute exacerbation COPD. 19 A recent study also reveals the correlation of miR-125a with CRP, IL-
17, TNF-α, and Crohn's disease activity index in patients with active
Crohn's disease. 24 In addition, the association of miR-125a and miR-125b with oxygen and glucose deprivation via regulating reactive oxygen species (ROS) level is reported in several organs, such as lung and kidney. 13, 14 In our present study, we found that miR-125a was positively associated with Scr, APACHE II score, and SOFA score, Considering the findings that miR-125a and miR-125b were associated with higher inflammatory level and advanced disease severity in sepsis patients, we further explored the association of miR-125a
and miR-125b with survival profiles in sepsis patients. We observed that miR-125b but not miR-125a was upregulated in deaths compared with survivors in sepsis patients. The possible explanations might be that (a) according to the previous findings, miR-125a was associated with APACHE II score and SOFA score, and there was no association of miR-125a with systematic inflammation and lung injuries, therefore, miR-125a lacked power to predict mortality in sepsis patients. (b) as for miR-125b, it was not only associated with disease severity, but also correlated with systematic inflammation and multiple organ dysfunction (such as renal and lung), which suggested the potential value of miR-125b in predicting mortality in sepsis patients.
There were several limitations in our study. (a) The sample size of our study was relatively low, thus study with a larger sample size was needed for validation in the future. (b) The sample size was relatively small to achieve strong statistical power; thus, a large sample size was needed for validation. (c) The underlying mechanism of miR-125a and miR-125b was not included in our present study, which needed further exploration.
MiR-125a and miR-125b correlates with increased ARDS risk and disease severity of sepsis, while only miR-125b associates with elevated systemic inflammation and raised mortality in sepsis patients.
These imply miR-125b might be a potential marker for the management of sepsis.
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